Clinical Trial Update: Surfactant Administration During Spontaneous Breathing [Phase 4]

View source ↗

Summary

A Phase 4 trial update examining surfactant administration during spontaneous breathing; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Pneumothorax
• Pulmonary Interstitial Emphysema

Drugs mentioned

• Surfactant (surfactant)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Pneumothorax, Pulmonary Interstitial Emphysema | Phase 4 | Status: UNKNOWN